Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-25
2005-10-25
Shah, Mukund J. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235500, C514S235800, C514S252110, C514S253010, C514S253110, C514S318000, C514S330000, C514S603000, C544S060000, C544S121000, C544S124000, C544S129000, C544S160000, C544S360000, C544S364000, C546S193000, C546S194000, C546S225000, C546S226000, C564S086000
Reexamination Certificate
active
06958331
ABSTRACT:
The invention relates to sulfonyl amine derivatives of formula IAwherein R5A, X1, X2, R9and R10are as defined herein, which derivatives are useful as bradykinin B1receptor antagonists.
REFERENCES:
patent: 6100278 (2000-08-01), Ferrari et al.
patent: WO 97/25315 (1997-07-01), None
Marceau F, Hess JF, Bachvarov DR, “The B1 receptors for kinins”, Pharmacol Rev. Sep. 1998;50(3):357-86.
Streitwieser, A. and Heathcock, C.H., “Introduction to Organic Chemistry, 2nd Ed.”, Macmillan, New York, 1981, p. 515.
Brain Christopher Thomas
Cantrell William
Culshaw Andrew James
Dziadulewicz Edward Karol
Hart Terance William
Borovian Joseph J.
McKenzie Thomas
Novartis AG
Shah Mukund J.
Wilusz E. Jay
LandOfFree
Bradykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bradykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bradykinin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3463458